Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
17
DRPRY Quote, Financials, Valuation and Earnings
Last price:
$4.83
Seasonality move
:
-11.3%
Day range:
$4.84 - $4.93
52-week range:
$4.39 - $8.31
Dividend yield:
10.45%
P/E ratio:
9.09x
P/S ratio:
0.78x
P/B ratio:
1.83x
Volume:
327.2K
Avg. volume:
211K
1-year change:
-37.74%
Market cap:
$44.6B
Revenue:
$43.9B
EPS (TTM):
$0.86
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.9B | $32.8B | $39.2B | $39.7B | $43.9B | |
| Revenue Growth (YoY) | 4.86% | 2.65% | 19.65% | 1.23% | 10.55% | |
| Cost of Revenues | $23.8B | $24.2B | $28.7B | $28.6B | $31.3B | |
| Gross Profit | $8.1B | $8.6B | $10.5B | $11.1B | $12.6B | |
| Gross Profit Margin | 25.47% | 26.28% | 26.73% | 28.03% | 28.64% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.4B | $3.6B | $4.2B | $4.2B | $5B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.2B | $3.8B | $4.3B | $4.2B | $4.8B | |
| Operating Income | $5B | $4.8B | $6.2B | $6.9B | $7.7B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.5B | $5B | $6.8B | $7.5B | $8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4B | $1.4B | $2B | $2.2B | $2.4B | |
| Net Income to Company | $4.5B | $5B | $6.8B | $7.5B | $8B | |
| Minority Interest in Earnings | -$5.6M | -$4.6M | -$7.1M | -$7.4M | -- | |
| Net Income to Common Excl Extra Items | $3.1B | $3.6B | $4.8B | $5.2B | $5.6B | |
| Basic EPS (Cont. Ops) | $0.69 | $0.79 | $1.05 | $0.57 | $0.61 | |
| Diluted EPS (Cont. Ops) | $0.69 | $0.79 | $1.05 | $0.57 | $0.61 | |
| Weighted Average Basic Share | $4.6B | $4.6B | $4.6B | $9.1B | $9.1B | |
| Weighted Average Diluted Share | $4.6B | $4.6B | $4.6B | $9.1B | $9.1B | |
| EBITDA | $8.1B | $9B | $10.7B | $10.9B | $12B | |
| EBIT | $4.7B | $5.2B | $6.9B | $7.6B | $8.2B | |
| Revenue (Reported) | $31.9B | $32.8B | $39.2B | $39.7B | $43.9B | |
| Operating Income (Reported) | $5B | $4.8B | $6.2B | $6.9B | $7.7B | |
| Operating Income (Adjusted) | $4.7B | $5.2B | $6.9B | $7.6B | $8.2B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $9B | $10.8B | $9.8B | |
| Revenue Growth (YoY) | -- | -- | -- | 20.16% | -9.75% | |
| Cost of Revenues | -- | -- | $6.6B | $7.8B | $7.3B | |
| Gross Profit | -- | -- | $2.5B | $3B | $2.5B | |
| Gross Profit Margin | -- | -- | 27.19% | 27.9% | 25.71% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $907.8M | $1.1B | $1.2B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | $807.9M | $1B | $1.1B | |
| Operating Income | -- | -- | $1.6B | $2B | $1.4B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | $1.7B | $2.1B | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $561.1M | $620.8M | $441M | |
| Net Income to Company | -- | -- | $1.7B | $2.1B | $1.4B | |
| Minority Interest in Earnings | -- | -- | -$3.4M | -- | $1.1M | |
| Net Income to Common Excl Extra Items | -- | -- | $1.1B | $1.5B | $1B | |
| Basic EPS (Cont. Ops) | -- | -- | $0.25 | $0.17 | $0.11 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.25 | $0.17 | $0.11 | |
| Weighted Average Basic Share | -- | -- | $4.6B | $4.6B | $9.2B | |
| Weighted Average Diluted Share | -- | -- | $4.6B | $4.6B | $9.2B | |
| EBITDA | -- | -- | $2.5B | $2.7B | $2.4B | |
| EBIT | -- | -- | $1.6B | $2B | $1.4B | |
| Revenue (Reported) | -- | -- | $9B | $10.8B | $9.8B | |
| Operating Income (Reported) | -- | -- | $1.6B | $2B | $1.4B | |
| Operating Income (Adjusted) | -- | -- | $1.6B | $2B | $1.4B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $41.4B | $42.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $29.7B | $30.8B | |
| Gross Profit | -- | -- | -- | $11.7B | $12.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $4.4B | $5.2B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | $4.4B | $4.9B | |
| Operating Income | -- | -- | -- | $7.3B | $7.1B | |
| Net Interest Expenses | -- | -- | -- | -- | $12.4M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $7.9B | $7.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $2.3B | $2.2B | |
| Net Income to Company | -- | -- | -- | $7.9B | $7.3B | |
| Minority Interest in Earnings | -- | -- | -$4.5M | -$4.2M | $1.1M | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $5.6B | $5.1B | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $1.06 | $0.86 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $1.06 | $0.86 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $11.2B | $11.7B | |
| EBIT | -- | -- | -- | $7.9B | $7.6B | |
| Revenue (Reported) | -- | -- | -- | $41.4B | $42.8B | |
| Operating Income (Reported) | -- | -- | -- | $7.3B | $7.1B | |
| Operating Income (Adjusted) | -- | -- | -- | $7.9B | $7.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $9B | $10.8B | $9.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $6.6B | $7.8B | $7.3B | -- | |
| Gross Profit | -- | $2.5B | $3B | $2.5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $907.8M | $1.1B | $1.2B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $807.9M | $1B | $1.1B | -- | |
| Operating Income | -- | $1.6B | $2B | $1.4B | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | $1.7B | $2.1B | $1.4B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $561.1M | $620.8M | $441M | -- | |
| Net Income to Company | -- | $1.7B | $2.1B | $1.4B | -- | |
| Minority Interest in Earnings | -- | -$3.4M | -- | $1.1M | -- | |
| Net Income to Common Excl Extra Items | -- | $1.1B | $1.5B | $1B | -- | |
| Basic EPS (Cont. Ops) | -- | $0.25 | $0.17 | $0.11 | -- | |
| Diluted EPS (Cont. Ops) | -- | $0.25 | $0.17 | $0.11 | -- | |
| Weighted Average Basic Share | -- | $4.6B | $4.6B | $9.2B | -- | |
| Weighted Average Diluted Share | -- | $4.6B | $4.6B | $9.2B | -- | |
| EBITDA | -- | $2.5B | $2.7B | $2.4B | -- | |
| EBIT | -- | $1.6B | $2B | $1.4B | -- | |
| Revenue (Reported) | -- | $9B | $10.8B | $9.8B | -- | |
| Operating Income (Reported) | -- | $1.6B | $2B | $1.4B | -- | |
| Operating Income (Adjusted) | -- | $1.6B | $2B | $1.4B | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.9B | $5.5B | $5.3B | $4B | $6.4B | |
| Short Term Investments | $3.2B | $4.1B | $7B | $7.5B | $3.5B | |
| Accounts Receivable, Net | $1.9B | $2.7B | $2.6B | $3B | $3.4B | |
| Inventory | $4.5B | $5B | $5.1B | $5.6B | $6.2B | |
| Prepaid Expenses | $1.1M | $72.6M | $38.5M | $261.7M | $368.1M | |
| Other Current Assets | -- | -- | -- | -- | -$1.1M | |
| Total Current Assets | $14.2B | $18.6B | $21B | $21.6B | $22.2B | |
| Property Plant And Equipment | $13.9B | $15.1B | $14.4B | $13.7B | $15B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $10.1M | $11.1M | $10.2M | $20.4M | $19.9M | |
| Other Intangibles | $5.7B | $6.7B | $7B | $8B | $9.4B | |
| Other Long-Term Assets | -- | -- | -- | -- | $2.2M | |
| Total Assets | $47.5B | $56B | $58.2B | $51.1B | $55.8B | |
| Accounts Payable | $2.9B | $2.9B | $2.8B | $3.1B | $3.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $89.6M | $111.9M | $121.1M | $113.7M | $124.9M | |
| Other Current Liabilities | $174.7M | $198M | $237.8M | $278.8M | $277.5M | |
| Total Current Liabilities | $12.7B | $13.9B | $14.8B | $17.8B | $15B | |
| Long-Term Debt | $5.1B | $5.9B | $6.4B | $5.4B | $6.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $27.9B | $31.1B | $32.2B | $32.8B | $31.8B | |
| Common Stock | $50.4M | $55.3M | $50.9M | $977M | $1B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $19.5B | $24.9B | $26B | $18.3B | $24B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $5.6M | $6.1M | $9.1M | $8.6M | $1.1M | |
| Total Equity | $19.5B | $24.9B | $26B | $18.3B | $24B | |
| Total Liabilities and Equity | $47.5B | $56B | $58.2B | $51.1B | $55.8B | |
| Cash and Short Terms | $7.1B | $9.7B | $12.3B | $11.5B | $10B | |
| Total Debt | $7.5B | $9.1B | $9.8B | $9B | $10.3B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $2.3B | $6.7B | |
| Short Term Investments | -- | -- | -- | $8.9B | $6.3B | |
| Accounts Receivable, Net | -- | -- | -- | $1.7B | $1.8B | |
| Inventory | -- | -- | -- | $6.8B | $7.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $19.7B | $22.2B | |
| Property Plant And Equipment | -- | -- | -- | $13.9B | $14.8B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $1.1M | -- | |
| Total Assets | -- | -- | -- | $50.3B | $56.1B | |
| Accounts Payable | -- | -- | -- | $3.8B | $4.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | $7.1B | $6.7B | |
| Total Current Liabilities | -- | -- | -- | $14.5B | $15.2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $30B | $31.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $20.3B | $24.3B | |
| Total Liabilities and Equity | -- | -- | -- | $50.3B | $56.1B | |
| Cash and Short Terms | -- | -- | -- | $11.2B | $13B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.5B | $5B | $6.8B | $7.5B | $8B | |
| Depreciation & Amoritzation | $3.4B | $3.8B | $3.8B | $3.4B | $3.8B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$714.2M | -$2B | -$1.5B | -$1.3B | -$904M | |
| Change in Inventories | -$96.3M | -$254.7M | -$179.8M | -$1.1B | -$751.3M | |
| Cash From Operations | $5B | $4.7B | $7.6B | $7.5B | $7.6B | |
| Capital Expenditures | $3.4B | $3.2B | -- | $3.9B | $4.4B | |
| Cash Acquisitions | -$72.8M | -$52.5M | -- | -$475.6M | -$254.4M | |
| Cash From Investing | -$4B | -$3.4B | -$7.1B | -$7B | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.1B | -$2.2B | -$3.5B | -$991.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.7B | $3.7B | -- | $4.6B | $6.1B | |
| Long-Term Debt Repaid | -$2.7B | -$2.9B | -- | -$5B | -$4.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $788.1M | $322.1M | $1B | -$257.3M | -$4.3B | |
| Cash From Financing | -$395.2M | $89.1M | -$612.9M | -$1.1B | -$4B | |
| Beginning Cash (CF) | $2.9B | $3.6B | $5.1B | $4.6B | $4.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $577.7M | $1.4B | -$79.3M | -$612.7M | $2.3B | |
| Ending Cash (CF) | $3.6B | $5B | $5.1B | $3.9B | $6.3B | |
| Levered Free Cash Flow | $1.7B | $1.6B | $7.6B | $3.6B | $3.2B | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $1.7B | $2.1B | $1.4B | |
| Depreciation & Amoritzation | -- | -- | $824.8M | $773.3M | $1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -$351.2M | -$51.6M | $13M | |
| Change in Inventories | -- | -- | -$585.7M | -$845.3M | -$608.3M | |
| Cash From Operations | -- | -- | $1.6B | $2.4B | $1.7B | |
| Capital Expenditures | -- | -- | -- | $922.6M | $1.4B | |
| Cash Acquisitions | -- | -- | -- | -$46.2M | -$247.7M | |
| Cash From Investing | -- | -- | $488.1M | $94.5M | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$2.1B | -$4.3B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $1.2B | $998.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -$1B | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$150.4M | -$103.1M | $39.1M | |
| Cash From Financing | -- | -- | -$1.9B | -$4.2B | -$47.8M | |
| Beginning Cash (CF) | -- | -- | $4.9B | $4B | $6.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | $9M | -$16.1M | $9.8M | |
| Additions / Reductions | -- | -- | $148.1M | -$1.7B | $363.9M | |
| Ending Cash (CF) | -- | -- | $5B | $2.3B | $6.7B | |
| Levered Free Cash Flow | -- | -- | $1.6B | $1.5B | $342.2M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $7.9B | $7.3B | |
| Depreciation & Amoritzation | -- | -- | -- | $3.3B | $4.1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$997.5M | -$839.4M | |
| Change in Inventories | -- | -- | -- | -$1.3B | -$514.3M | |
| Cash From Operations | -- | -- | -- | $8.3B | $6.9B | |
| Capital Expenditures | -- | -- | -- | $4.8B | $4.9B | |
| Cash Acquisitions | -- | -- | -- | -$521.8M | -$455.9M | |
| Cash From Investing | -- | -- | -- | -$7.4B | -$2.7B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$2.1B | -$5.7B | $3.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $5.8B | $5.9B | |
| Long-Term Debt Repaid | -- | -- | -- | -$6B | -$4.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$210.1M | -$4.2B | |
| Cash From Financing | -- | -- | -- | -$3.4B | $157.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$2.5B | $4.4B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $3.5B | $2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $1.7B | $2.1B | $1.4B | -- | |
| Depreciation & Amoritzation | -- | $824.8M | $773.3M | $1B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -$351.2M | -$51.6M | $13M | -- | |
| Change in Inventories | -- | -$585.7M | -$845.3M | -$608.3M | -- | |
| Cash From Operations | -- | $1.6B | $2.4B | $1.7B | -- | |
| Capital Expenditures | -- | -- | $922.6M | $1.4B | -- | |
| Cash Acquisitions | -- | -- | -$46.2M | -$247.7M | -- | |
| Cash From Investing | -- | $488.1M | $94.5M | -$1.3B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$2.1B | -$4.3B | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $1.2B | $998.2M | -- | |
| Long-Term Debt Repaid | -- | -- | -$1B | -$1.1B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$150.4M | -$103.1M | $39.1M | -- | |
| Cash From Financing | -- | -$1.9B | -$4.2B | -$47.8M | -- | |
| Beginning Cash (CF) | -- | $4.9B | $4B | $6.3B | -- | |
| Foreign Exchange Rate Adjustment | -- | $9M | -$16.1M | $9.8M | -- | |
| Additions / Reductions | -- | $148.1M | -$1.7B | $363.9M | -- | |
| Ending Cash (CF) | -- | $5B | $2.3B | $6.7B | -- | |
| Levered Free Cash Flow | -- | $1.6B | $1.5B | $342.2M | -- | |
Get DRPRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DRPRY
Sector
P/E ratio
9.09x
16.92x
PEG ratio
--
0.17x
P/B ratio
1.83x
1.42x
Price / LTM sales
0.78x
0.68x
Growth Metrics
DRPRY
Sector
Revenue growth
-9.75%
0.64%
Earnings growth
-33.67%
-1.02%
Revenue (5-year growth)
7.58%
3.61%
Earnings forecast
--
$0.24
Profitability
DRPRY
Sector
Profitability FY 2023
$12.6B
$456.7M
Return on invested capital
19.34%
4.58%
Return on assets
9.46%
2.72%
Return on equity
22.74%
6.7%
Earnings Date
Last Earnings Date
Apr
29
Next Earnings Date
Jul
24
Estimated Next Earnings Date
Jul
29
Balance Sheet
DRPRY
Sector
Total cash
$13B
$139.6M
Short term investments
$3.5B
$46.8M
Total assets
$55.8B
$1.4B
Long term debt
--
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
